Vaccine Update 315 - Rotarix resource discrepancy in date estimate
12 January 2023
|
|
GlaxoSmithKline (GSK) has advised that discrepancies have been identified in some copies of the Rotarix Dosing and Administration Wheel (Rotarix Wheel).
Immunisations providers and practice staff are encouraged to immediately cease use of the Rotarix Wheel resource from GSK if they are in possession of any copies and to discard this resource. GSK will refresh the resource shortly. Image of the Rotarix Wheel is included below for reference.
Please note there is no impact to the Rotarix vaccine.
The Rotarix Product Information remains correct, the vaccination course consists of two doses. The first dose should be given between 6 and 14 weeks of age. The interval between the two doses should not be less than 4 weeks. The vaccine course should be completed by the age of 24 weeks per the WA Immunisation Schedule.
For information on GSK products, please contact GSK Medical Information on 1800 033 109.
To report an adverse event following immunisation, please use the SAFEVAC Reporting to notify the WA Vaccine Safety Surveillance (WAVSS) system.
|
|
|
|
